Crinetics Pharmaceuticals (CRNX) Shares Outstanding (2017 - 2026)

Crinetics Pharmaceuticals' Shares Outstanding history runs 10 years deep, the most recent figure standing at $105.3 million for Q1 2026.

• In Q1 2026, Shares Outstanding rose 12.61% year-over-year to $105.3 million; the TTM figure through Mar 2026 stood at $105.3 million (up 12.61% YoY), while the FY2025 annual figure was $95.6 million, up 2.85% from the prior year.
• Shares Outstanding was $105.3 million for Q1 2026 at Crinetics Pharmaceuticals, up from $95.6 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $105.3 million in Q1 2026 to a low of $4.8 million in Q1 2022.
• Historically, Shares Outstanding has averaged $72.0 million across 5 years, with a median of $78.5 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Shares Outstanding plunged 85.52% in 2022, then surged 1029.5% in 2023.
• A 5-year view of Shares Outstanding shows it stood at $53.9 million in 2022, then advanced by 26.54% to $68.2 million in 2023, then soared by 36.31% to $92.9 million in 2024, then rose by 2.85% to $95.6 million in 2025, then gained by 10.19% to $105.3 million in 2026.
• The last three Shares Outstanding figures came in at $105.3 million (Q1 2026), $95.6 million (Q4 2025), and $94.5 million (Q3 2025), per Business Quant data.